How have LBL shares performed in 2024?

Lattice Biologics' stock was trading at C$0.04 on January 1st, 2024. Since then, LBL stock has increased by 0.0% and is now trading at C$0.04. View the best growth stocks for 2024 here .

What other stocks do shareholders of Lattice Biologics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lattice Biologics investors own include Cross Timbers Royalty Trust (CRT) , 50904 (GRC.V) (GRC) , InfraCap MLP ETF (AMZA) , Alliance Resource Partners (ARLP) , Brigham Minerals (MNRL) , Sorrento Therapeutics (SRNE) , Arbor Realty Trust (ABR) , Advanced Emissions Solutions (ADES) and Archer-Daniels-Midland (ADM) .

How do I buy shares of Lattice Biologics?

Shares of LBL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:LBL

Lattice Biologics (LBL) Stock Price, News & Analysis

→ Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars (From GoldenCrest Metals) (Ad)

Free LBL Stock Alerts

C$0.04

0.00 (0.00%)

(As of 06/3/2021)

Compare

Today's Range: C$0.04
▼
C$0.04
50-Day Range: C$0.04
▼
C$0.04
52-Week Range: C$0.03
▼
C$0.13

Volume: 114,000 shs
Average Volume: 468,022 shs
Market Capitalization: C$5.13 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Lattice Biologics alerts:

Ad GoldenCrest Metals

Emergency: Biden's $20 Trillion Mistake Could Cost YOU!

The stakes have never been higher for your savings. Here's the hard truth: A banking crisis is looming. Your money is in the crosshairs of a $20 trillion commercial loan debt disaster, set to erupt.

Learn More Now

About Lattice Biologics

Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops novel amniotic fluid-based products, such as AmnioBoost and AmnioBlast. The company also offers traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana.

LBL Stock Price History

30 days | 90 days | 365 days | Advanced Chart

LBL Stock News Headlines

January 10, 2024 | seekingalpha.com

IVBIY Innovent Biologics, Inc.

May 7, 2023 | seekingalpha.com

AbCellera Biologics GAAP EPS of -$0.14, revenue of $12M

April 18, 2024 | The Freeport Society (Ad)

Next President (Not Trump. Not Biden.)

Do you want to see who I believe will be the next president of the U.S.A? It won't be Biden… And it won't be Trump.

March 28, 2023 | benzinga.com

ADMA Biologics Stock (NASDAQ:ADMA), Analyst Ratings, Price Targets, Predictions

March 2, 2023 | investing.com

Lattice Biologics Ltd (LBLh)

September 23, 2022 | markets.businessinsider.com

Lattice Announces Lattice Connect Partner Ecosystem to Help Organizations Maximize People Success

September 9, 2022 | morningstar.com

Lattice Semiconductor Corp LSCC Stock Quote

October 26, 2021 | finance.yahoo.com

Notice of Lattice Biologics Ltd. Year End 2016 Financial Results Conference Call

See More Headlines

Receive LBL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lattice Biologics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: CVE:LBL
CUSIP: N/A
CIK: N/A
Web: www.latticebiologics.com
Phone: +1-604-2356701
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.02
Quick Ratio: 0.02

Sales & Book Value

Annual Sales: C$1.56 million
Price / Sales: 3.29
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: C$0.00 per share
Price / Book: 40.00

Miscellaneous

Outstanding Shares: 128,218,000
Free Float: N/A
Market Cap: C$5.13 million
Optionable: Not Optionable
Beta: N/A

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Mr. Guy S. Cook (Age 56)
Chairman, Pres & CEO
Comp: $360k
Ms. Donna Medina
Interim Chief Financial Officer

Key Competitors

View All Competitors

LBL Stock Analysis - Frequently Asked Questions

How have LBL shares performed in 2024?: Lattice Biologics' stock was trading at C$0.04 on January 1st, 2024. Since then, LBL stock has increased by 0.0% and is now trading at C$0.04.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Lattice Biologics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Lattice Biologics investors own include Cross Timbers Royalty Trust (CRT), 50904 (GRC.V) (GRC), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Brigham Minerals (MNRL), Sorrento Therapeutics (SRNE), Arbor Realty Trust (ABR), Advanced Emissions Solutions (ADES) and Archer-Daniels-Midland (ADM).
How do I buy shares of Lattice Biologics?: Shares of LBL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:LBL) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial